Financials Ascend Wellness Holdings, Inc.
Equities
AAWH.U
US04351N1063
Healthcare Facilities & Services
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.99 USD | +4.21% |
|
+10.00% | +2.06% |
06-20 | Ascend Wellness Holdings Inc. Brief: Opening a New Dispensary in Wharton, New Jersey, on June 28, 2024 | MT |
06-19 | Ascend Wellness Opens Fourth Dispensary in Pennsylvania, 37th in Seven States | MT |
Valuation
Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|
Capitalization 1 | 1,145 | 217 | 200.7 | 202.6 | - | - |
Enterprise Value (EV) 1 | 1,448 | 705.9 | 436.9 | 511.8 | 468.1 | 595.6 |
P/E ratio | - | -2.61 x | -4.04 x | -4.83 x | -10.6 x | -7.62 x |
Yield | - | - | - | - | - | - |
Capitalization / Revenue | 3.45 x | 0.53 x | 0.39 x | 0.35 x | 0.33 x | 0.3 x |
EV / Revenue | 4.36 x | 1.74 x | 0.84 x | 0.87 x | 0.76 x | 0.89 x |
EV / EBITDA | 18.2 x | 7.57 x | 4.1 x | 4.01 x | 3.25 x | 3.88 x |
EV / FCF | -11.1 x | -5.88 x | 8.55 x | 23.3 x | 10.7 x | 12.2 x |
FCF Yield | -8.99% | -17% | 11.7% | 4.29% | 9.31% | 8.23% |
Price to Book | 6.43 x | 1.29 x | 1.35 x | 1.77 x | 1.94 x | 2.15 x |
Nbr of stocks (in thousands) | 173,248 | 188,662 | 206,871 | 213,283 | - | - |
Reference price 2 | 6.610 | 1.150 | 0.9700 | 0.9900 | 0.9900 | 0.9900 |
Announcement Date | 3/8/22 | 3/14/23 | 3/12/24 | - | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|
Net sales 1 | 143.7 | 332.4 | 405.9 | 518.6 | 585.6 | 618.8 | 669.2 |
EBITDA 1 | - | 79.43 | 93.22 | 106.5 | 127.6 | 144 | 153.4 |
EBIT 1 | - | -17.2 | -7.526 | -3.619 | 25.9 | 54 | 74 |
Operating Margin | - | -5.18% | -1.85% | -0.7% | 4.42% | 8.73% | 11.06% |
Earnings before Tax (EBT) 1 | - | - | -39.21 | -14.76 | - | - | - |
Net income 1 | -25.44 | - | -80.9 | -48.21 | -39.7 | -12.05 | - |
Net margin | -17.7% | - | -19.93% | -9.3% | -6.78% | -1.95% | - |
EPS 2 | -0.1300 | - | -0.4400 | -0.2400 | -0.2050 | -0.0933 | -0.1300 |
Free Cash Flow 1 | - | -130.2 | -120 | 51.09 | 21.95 | 43.58 | 49 |
FCF margin | - | -39.16% | -29.56% | 9.85% | 3.75% | 7.04% | 7.32% |
FCF Conversion (EBITDA) | - | - | - | 47.96% | 17.21% | 30.26% | 31.93% |
FCF Conversion (Net income) | - | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - | - |
Announcement Date | 2/26/21 | 3/8/22 | 3/14/23 | 3/12/24 | - | - | - |
Income Statement Evolution (Quarterly data)
Fiscal Period: December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales 1 | 88.5 | 85.09 | 97.5 | 111.2 | 112.1 | 114.2 | 123 | 141.3 | 140.2 | 142.4 | 145.4 | 147.9 | 150.4 | 154 | 156.6 |
EBITDA 1 | 19.76 | 16.37 | 20.89 | 27.77 | 28.19 | 23.31 | 21.32 | 29.52 | 32.35 | 32.48 | 31.15 | 32.15 | 32.29 | 33.77 | 35.8 |
EBIT 1 | -0.731 | -14.78 | -0.605 | 2.477 | 5.382 | 0.255 | -7.985 | 3.547 | 0.564 | 2.575 | 9.6 | 11.2 | 10.5 | - | - |
Operating Margin | -0.83% | -17.37% | -0.62% | 2.23% | 4.8% | 0.22% | -6.49% | 2.51% | 0.4% | 1.81% | 6.6% | 7.57% | 6.98% | - | - |
Earnings before Tax (EBT) 1 | - | - | -9.7 | -5.684 | -3.114 | -8.455 | 5.578 | -4.514 | -7.369 | -5.653 | - | 2 | - | - | - |
Net income 1 | - | - | -21.17 | -16.86 | -15.05 | -18.74 | 0.841 | -11.24 | -19.34 | -18.16 | -13.6 | -12.4 | -11.9 | - | - |
Net margin | - | - | -21.72% | -15.16% | -13.43% | -16.42% | 0.68% | -7.96% | -13.8% | -12.75% | -9.35% | -8.38% | -7.91% | - | - |
EPS 2 | - | - | -0.1100 | -0.0900 | -0.0800 | -0.1000 | 0.004300 | -0.0500 | -0.0900 | -0.0900 | -0.0600 | -0.0550 | -0.0550 | - | - |
Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Announcement Date | 3/8/22 | 5/11/22 | 8/15/22 | 11/10/22 | 3/14/23 | 5/9/23 | 8/8/23 | 11/7/23 | 3/12/24 | 5/7/24 | - | - | - | - | - |
Balance Sheet Analysis
Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|
Net Debt 1 | - | 303 | 489 | 236 | 309 | 265 | 393 |
Net Cash position 1 | - | - | - | - | - | - | - |
Leverage (Debt/EBITDA) | - | 3.818 x | 5.245 x | 2.218 x | 2.424 x | 1.844 x | 2.561 x |
Free Cash Flow 1 | - | -130 | -120 | 51.1 | 22 | 43.6 | 49 |
ROE (net income / shareholders' equity) | - | -76.4% | - | -31.5% | -17.5% | -4.8% | - |
ROA (Net income/ Total Assets) | - | -12% | - | -1.72% | 7.3% | 8.4% | - |
Assets 1 | - | - | - | 2,802 | -543.8 | -143.5 | - |
Book Value Per Share 2 | - | 1.030 | 0.8900 | 0.7200 | 0.5600 | 0.5100 | 0.4600 |
Cash Flow per Share 2 | - | -0.2800 | -0.2100 | 0.3800 | 0.3200 | 0.3900 | - |
Capex 1 | - | 88.4 | 81.6 | 24.2 | 34.9 | 22 | 10 |
Capex / Sales | - | 26.6% | 20.11% | 4.68% | 5.95% | 3.56% | 1.49% |
Announcement Date | 2/26/21 | 3/8/22 | 3/14/23 | 3/12/24 | - | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+2.06% | 203M | |
+30.04% | 254M | |
+27.91% | 158M | |
+43.67% | 129M | |
-42.86% | 121M | |
+300.00% | 121M | |
+71.19% | 99.12M | |
-51.13% | 86.63M | |
-23.08% | 83.53M |
- Stock Market
- Equities
- AAWH.U Stock
- Financials Ascend Wellness Holdings, Inc.